TD Cowen Downgrades Ginkgo Bioworks Holdings to Hold, Lowers Price Target to $9
Benzinga Newsdesk 2 months ago
Analyst RatingsNewsDowngradesPrice Target
TD Cowen analyst Brendan Smith downgrades Ginkgo Bioworks Holdings (NYSE:DNA) from Buy to Hold and lowers the price target from $12 to $9.
TD Cowen analyst Brendan Smith downgrades Ginkgo Bioworks Holdings (NYSE:DNA) from Buy to Hold and lowers the price target from $12 to $9.